• Home
  • Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques
  • Home
  • Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques

Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques

Topic:
  • Intervention
  • Structural Heart Disease

Course Published On:

Course Expiry Date:

Register now Log in

Target Audience

This programme is intended to educate:

  • Cardiologists, interventionalists and surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease, and interventional cardiology nurses

Learning Objectives

The symposium, ‘Optimising outcomes for the TAVI patient: Key Considerations for First Valve Choice and Implantation Techniques’, endeavours to best address the following learning objectives:

  • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
  • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
  • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
Register now Log in

Module

Title

Duration

Speakers
Welcome Welcome and Introduction Didier Tchétché
Session 1 Considerations for first valve choice Ran Kornowski
Session 2 Optimised approaches for long-term success Lars Søndergaard
Session 3 Tips and tricks for achieving procedure efficiencies Douglas G Fraser
Welcome.

Welcome and Introduction

Duration:

Speakers: Didier Tchétché

Session 1.

Considerations for first valve choice

Duration:

Speakers: Ran Kornowski

Session 2.

Optimised approaches for long-term success

Duration:

Speakers: Lars Søndergaard

Session 3.

Tips and tricks for achieving procedure efficiencies

Duration:

Speakers: Douglas G Fraser

Chair

Didier Tchétché

Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France

Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004.

View full profile

Panelist

Lars Søndergaard

Copenhagen University Hospital, Rigshospitalet, Copenhagen, DK

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters.

View full profile

Ran Kornowski

Rabin Medical Center, Petach Tikva, Israel , Cardiology Department, Rabin Medical Center, Petah Tikva, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Prof Ran Kornowski, MD, FACC, FESC is the Director of the Cardiology Division at Rabin Medical Center (RMC) in Petach Tikva, Israel.

View full profile

Douglas G Fraser

Manchester Heart Centre, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Trust, Manchester

Dr Douglas Fraser trained preclinical in Oxford and clinical in Cambridge, qualifying in 1991. House jobs in Addenbrooke’s, SHO and registrar training in the West Midlands including QE Birmingham, Walsgrave Coventry, North Staffordshire. One year fellowship in Amsterdam.

View full profile

This course is not CME accredited. 

Register now Log in

Related Courses

Individualising Antithrombotic Strategies for Established CAD
Individualising Antithrombotic Strategies for Established CAD

Marco Valgimigli Eliano Navarese Vijay Kunadian et al

  • 1.00 European Board for Accreditation of Continuing Education for Health Professionals (EBAC)

Published:

Learning objectives

  • Summarise current guidance for choosing antithrombotic therapy in established CAD
  • Describe current gaps in clinical evidence and what is missing from current guidance
  • Adopt an evidence-based approach for managing patients with ACS and CCS
See more
Transcatheter Edge-to-Edge Repair
Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation

Marta Sitges Muriel Sprynger Anita W Asgar et al

  • 1.00 EBAC

Published:

Learning objectives

  • Recall the long-term outcomes of TEER from real-world and RCT data
  • Apply the results of real-world data to both simple and complex patients
  • Describe how TEER is being used to benefit a range of patients with MR
See more
Severe Aortic Stenosis: Stratifying Patients for Lifetime Management

Thomas Modine David Wood Victoria Delgado et al

  • 1 EBAC

Published:

Learning objectives

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
See more
Renal Denervation In The Real World: Practical Guidance For New Users

Roland E Schmieder Lale Tokgözoğlu Cara East et al

  • 1 EBAC

Published:

Learning objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success

Ole De Backer Colum Owens

  • 1 EBAC

Published:

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Transcatheter Interventions Online - Session 3.4: Debates

Nicolas M Van Mieghem Ajay J Kirtane Holger Thiele et al

  • 1 EBAC

Published:

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.3: Keynote & Controversies: Live Cases And Discussion

Roxana Mehran Nicolas M Van Mieghem David Hildick-Smith et al

  • 1 EBAC

Published:

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.1 & 3.2: Keynote & Controversies

Roxana Mehran Lars Søndergaard David Hildick-Smith et al

  • 1 EBAC

Published:

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.4 Practical Pearls Toward a More Advanced CTO Programme: Live Cases and Discussion

Roxana Mehran Nicolas M Van Mieghem Ajay J Kirtane et al

  • 1 EBAC

Published:

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.3: Practical Pearls Toward a More Advanced CTO Programme

Roxana Mehran Nicolas M Van Mieghem Ajay J Kirtane et al

  • 1 EBAC

Published:

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more